Kozak O V, Muzichenko L V, Trembach A M, Voit N U, Turicina V V
Institute of Oncology, Kiev, Ukraine.
Exp Oncol. 2006 Mar;28(1):75-9.
The aim of the work was to estimate the strength of influence of the first (131)I activity on the outcome of the first course of radioiodine treatment as compared with other variables such as remnants volume, size and number of metastases in lymph nodes.
68 adult patients with differentiated thyroid cancer have been treated with radioiodine after thyroidectomy. All patients had metastatic lesions in lymph nodes accumulating (131)I. Activities administered amounted from 1000 to 6000 MBq. From 1 to 4 courses of radioiodine therapy were necessary for total ablation of metastases and remnants. Logistic function has been used to describe the probability of the total ablation of metastases and thyroid remnants after the first course.
It was shown that the value of the first activity has the decisive influence on the treatment outcome. In patients included into analysis the outcome of the first course actually does not depend on level of radioiodine accumulation in pathological lymph nodes and effective half-time of (131)I excretion in remnants.
As a result, in the case of metastatic lesions in lymph nodes accumulating radioiodine the first activity should not be less then 5000 MBq with the aim of minimizing the number of courses. Outcome of the treatment only slightly depends on such factors as histology, the number and the size of metastases in lymph nodes.
本研究旨在评估首次(131)I活度对首次放射性碘治疗疗程结果的影响强度,并与其他变量(如残余甲状腺体积、转移灶大小及淋巴结转移数量)进行比较。
68例成年分化型甲状腺癌患者在甲状腺切除术后接受放射性碘治疗。所有患者的淋巴结转移灶均摄取(131)I。给予的活度为1000至6000MBq。为完全清除转移灶和残余甲状腺组织,需进行1至4个疗程的放射性碘治疗。采用逻辑函数描述首次疗程后转移灶和甲状腺残余组织完全清除的概率。
结果表明,首次活度值对治疗结果具有决定性影响。纳入分析的患者中,首次疗程的结果实际上并不取决于病理性淋巴结中放射性碘的摄取水平以及残余甲状腺组织中(131)I的有效半衰期。
因此,对于淋巴结有摄取放射性碘的转移灶患者,为尽量减少疗程数,首次活度不应低于5000MBq。治疗结果仅轻微依赖于组织学类型、淋巴结转移灶的数量和大小等因素。